Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Lemonade (LMND) Stock Price & Analysis

5,952 Followers

LMND Stock Chart & Stats

$39.55-$1.93(-4.65%)
At close: 4:00 PM EST
$40$45$50$55Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$39.11 - $41.88
52-Week Range
$39.11 - $99.90
Previous Close
$41.48
Volume
N/A
Average Volume (3M)
1.21M
Market Cap
$3.08B
Enterprise Value
$3.75B
Total Cash (Recent Filing)
$385.20M
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
―
Beta
1.71
Next Earnings
Mar 02, 2027 (Est.)
EPS Estimate
-0.25
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Accelerating Growth

Premium and revenue are expanding rapidly, while gross profit is also rising. This combination indicates stronger scale and customer adoption, giving Lemonade a larger base over which to spread technology and operating costs and supporting durable growth if underwriting remains controlled.

Conservative Balance Sheet

Zero reported debt and substantial assets reduce financing pressure while the company funds expansion. Positive operating and free cash flow add resilience and suggest the platform is moving toward internally supported growth, although profitability remains unfinished.

Technology-Driven Operating Leverage

Maintaining a nearly tripled premium base with fewer employees points to meaningful productivity from Lemonade’s proprietary AI platform. This operating leverage can support scalable distribution and claims administration, helping margin improvement as customer and policy volumes grow.

Bears Say

Continuing Losses

Lemonade remains loss-making, with negative TTM operating profit and EBITDA and a -13.5% net margin. Until underwriting and operating scale convert growth into consistent profit, future expansion remains dependent on execution and may produce weak returns on its capital base.

Elevated Operating Costs

Operating expenses rose 36% year over year, including 44% sales and marketing growth, while Q3 adjusted EBITDA remained negative. Sustained spending can delay breakeven and dilute operating leverage if acquisition and expansion do not generate enough recurring premium and gross profit.

Pet Underwriting Pressure

Pet insurance claims pressure threatens underwriting margin because veterinary-cost inflation has required rate actions and kept EBITDA guidance unchanged despite higher revenue guidance. If normalization takes longer, pricing changes may precede meaningful profitability from this product.

Lemonade News

LMND FAQ

What was Lemonade’s price range in the past 12 months?
Lemonade lowest stock price was $39.11 and its highest was $99.90 in the past 12 months.
What is Lemonade’s market cap?
Lemonade’s market cap is $3.08B.
When is Lemonade’s upcoming earnings report date?
Lemonade’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 112 days.
How were Lemonade’s earnings last quarter?
Lemonade released its earnings results on Nov 05, 2026. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.58 by $0.02.
Is Lemonade overvalued?
According to Wall Street analysts Lemonade’s price is currently Undervalued.
Does Lemonade pay dividends?
Lemonade does not currently pay dividends.
What is Lemonade’s EPS estimate?
Lemonade’s EPS estimate is -0.25.
How many shares outstanding does Lemonade have?
Lemonade has 77,921,210 shares outstanding.
What happened to Lemonade’s price movement after its last earnings report?
Lemonade reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.58. Following the earnings report the stock price went down -9.63%.
Which hedge fund is a major shareholder of Lemonade?
Hedge funds hold Lemonade shares: the largest hedge-fund position in Lemonade is 71,885,681 shares, and hedge funds increased their holdings by 1.2M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology